Trish Logie
About Trish Logie
Trish Logie serves as the Group Director of Regulatory Affairs at Dechra Pharmaceuticals PLC and holds multiple senior roles at Elanco, showcasing her extensive expertise in regulatory processes and veterinary science.
Work at Dechra Pharmaceuticals
Trish Logie has held the position of Group Director of Regulatory Affairs at Dechra Pharmaceuticals PLC since 2020. In this role, she oversees regulatory strategies and compliance for the company, contributing to its mission in the veterinary pharmaceutical sector. Her tenure at Dechra spans four years, during which she has focused on enhancing regulatory processes and ensuring that product development aligns with industry standards.
Current Role at Elanco
In addition to her role at Dechra, Trish Logie serves as a Senior Advisor (Director) of Global Regulatory for New Product Development at Elanco, a position she has held since 2019. She also functions as an Advisor (Director) of Global Regulatory Innovation at Elanco since 2015. Her responsibilities include guiding regulatory strategies for new products and fostering innovation within the regulatory framework.
Education and Expertise
Trish Logie studied Veterinary Medicine and Surgery at The University of Glasgow, where she earned her BVMS MRCVS from 1988 to 1993. This educational background provides her with a strong foundation in veterinary science, which is essential for her roles in Regulatory Affairs. She also attended King Edward VI, further contributing to her academic credentials.
Leadership and Management Skills
Trish Logie possesses a dynamic leadership style that is effective in managing global teams. Her experience in project and process improvement within Regulatory Affairs allows her to lead teams effectively and drive initiatives that enhance regulatory compliance and efficiency in both Dechra Pharmaceuticals and Elanco.